Kamada expands biosimilar portfolio with new launches
Kamada (NASDAQ:KMDA) expanded its commercial biosimilar portfolio in Israel with the market launch of Ustekinumab-Kamada and Enoxaparin-Kamada.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Kamada (NASDAQ:KMDA) expanded its commercial biosimilar portfolio in Israel with the market launch of Ustekinumab-Kamada and Enoxaparin-Kamada.
BD (NYSE:BDX) partnered with the U.S. government to expand domestic manufacturing and supply chain infrastructure for critical medical consumables.
Solidion Technology (NASDAQ:STI) announced it will not raise its all-cash proposal after Polar Power's board of directors rejected the asset offer.
Blaize (NASDAQ:BZAI) expects preliminary third-quarter 2026 revenue of approximately $0.5 million as quarter-end closing procedures continue.
ADX Energy (ASX:ADX) has announced a combined workover rig programme for its Austrian operations starting on Oct. 19.
Blockchain investigator ZachXBT said a Chinese organised crime syndicate had laundered over $1 billion for Lazarus Group.
Cotality reported that Australia's combined capital preliminary auction clearance rate dropped to 48.2% last week.
FinCEN has withdrawn two proposed rules covering digital asset transactions and cryptocurrency mixing.
Mader Group (ASX:MAD) has distributed $51.8 million worth of shares to staff after meeting its 2026 profit goals.
TeraWulf (NASDAQ:WULF) secured expanded electrical capacity to accelerate development at its Muskie Data Campus.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy